fashion -WSS

fashion

author：explore 2025-10-02 14:38:42 - browse：2218

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Printout prescription drug information shouldn’t go digital

leisure time

WSS

BMS, looking to build heart drug business, turns to AI for diagnosis

BMS, looking to build heart drug business, turns to AI for diagnosis

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Biogen’s boardroom scandal saddles CEO with first crisis

Cardiologists urge adding sexual orientation, gender identity to health records

Maui wildfire now ranks as the fifth

hotspot

fashion

Wikipedia

Wildfire smoke exposes gaps in outdoor worker protections

Mass General, Mayo Clinic look to monetize custom

Novavax promises a turnaround & Lilly roils the obesity market

Dozens dead from Maui wildfires: What we know about the victims

Cancer drug shortages should be causing more outrage

Dana Farber says 6 studies to be retracted and 31 corrected

Dobbs anniversary: the lost opportunity of abortion as health care

Dana Farber says 6 studies to be retracted and 31 corrected

Drug repurposing or repositioning? The language matters

After Optum profits sink, UnitedHealth makes changes

focus

Medicare drug price lawsuits could be good politics for Biden

Senators push IRS to launch nonprofit hospital probe

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

Idaho college killings prosecutors challenge defense's grand jury claims

Judge sides with young activists in first

leisure time

focus

focus

hotspot